Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations

PaperCitations, authors & open-access status

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 44 citations, 2018 year and gold oa status.

44
Citations
2018
Year
gold
OA Status

Related on ScholarIQ

Laia Sans-Atxer
Author
Dominique Joly
Author
International Journal of Nephrology and Renovascular Disease
Journal
Genetic and Kidney Cyst Diseases
Topic
Genetic and Kidney Cyst Diseases
Topic
Renal and related cancers
Topic
470M+ articles · free account